Vaginal Cancer Clinical Trials

20 recruiting

Vaginal Cancer Trials at a Glance

24 actively recruiting trials for vaginal cancer are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Chicago, Mianyang, and Canton. Lead sponsors running vaginal cancer studies include Shanghai Bovax Biotechnology Co., Ltd., Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Christian Hinrichs.

Browse vaginal cancer trials by phase

Treatments under study

About Vaginal Cancer Clinical Trials

Looking for clinical trials for Vaginal Cancer? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vaginal Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vaginal Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting

DESTINY-PANTUMOUR04

Liver CancerEsophageal CancerPancreatic Cancer+24 more
AstraZeneca100 enrolled17 locationsNCT07124000
Recruiting
Phase 2

Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies

Cervical CancerEndometrial CancerVaginal Cancer+4 more
University of Utah68 enrolled1 locationNCT05979610
Recruiting
Phase 1

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Malignant Female Reproductive System NeoplasmStage IV Cervical Cancer AJCC v8Stage IVA Cervical Cancer AJCC v8+22 more
M.D. Anderson Cancer Center24 enrolled2 locationsNCT03968406
Recruiting
Phase 1Phase 2

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Cervical CancerAnal CancerPenile Cancer+14 more
Christian Hinrichs15 enrolled2 locationsNCT05639972
Recruiting
Phase 2

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Cervical CancerMetastatic CancerAnal Cancer+18 more
Christian Hinrichs20 enrolled3 locationsNCT05686226
Recruiting
Not Applicable

3D Printed Custom Applicators for HDR BT (DISCO)

Endometrial CancerGynecologic CancerVaginal Cancer+1 more
Royal North Shore Hospital10 enrolled1 locationNCT06432478
Recruiting

Clinical Outcomes and Quality of Life in Patients With Locally Advanced Vulvovaginal Cancers: Ambispective Registration Study.

Vulvo-vaginal Cancer
Tata Memorial Hospital200 enrolled1 locationNCT07179757
Recruiting

Integrated Cancer Repository for Cancer Research

Breast CancerLiver CancerEsophageal Cancer+47 more
University of Nebraska999,999 enrolled45 locationsNCT02012699
Recruiting
Not Applicable

Image-Guided Gynecologic Brachytherapy

Cervical CancerBladder CancerUterine Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins54 enrolled1 locationNCT02993900
Recruiting
Phase 2

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Ovarian CancerCervical CancerEndometrial Cancer+5 more
Dana-Farber Cancer Institute32 enrolled2 locationsNCT06677190
Recruiting

Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer

Vaginal Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS278 enrolled1 locationNCT06314568
Recruiting
Not Applicable

Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence

Cervical CancersVaginal Cancers
Fondazione Policlinico Universitario Agostino Gemelli IRCCS64 enrolled1 locationNCT06867445
Recruiting
Not Applicable

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Ovarian CancerCervical CancerEndometrial Cancer+3 more
Ira Winer70 enrolled1 locationNCT06339827
Recruiting
Not Applicable

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Cervical CancerEndometrial CancerUterine Cancer+4 more
Northwestern University192 enrolled1 locationNCT05743517
Recruiting

NYSCF Scientific Discovery Biobank

Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106
Recruiting

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Ovarian CancerCervical CancerEndometrial Cancer+6 more
Northwestern University6,000 enrolled1 locationNCT00005095
Recruiting
Phase 2

A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer

Vulvar and Vaginal Cancer
Zhejiang Cancer Hospital40 enrolled1 locationNCT06292689
Recruiting

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

Ovarian CancerEndometrial CancerGynecologic Cancer+4 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1,800 enrolled1 locationNCT06284343
Recruiting
Phase 1

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

Cervical CancerAnal CancerPenile Cancer+5 more
The Affiliated Hospital of Qingdao University18 enrolled1 locationNCT06544720
Recruiting
Phase 3

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Cervical CancerVaginal CancerVulvar Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd.8,000 enrolled1 locationNCT04422366